Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fluorination . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116396201A details a safe, scalable DeoxoFluor route for (2R,4R)-4-fluoropyrrolidine-2-carboxylic acid, offering significant cost and safety advantages over traditional DAST methods.
Novel patent CN121426760A enables efficient synthesis. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN107522648B details a mild copper-catalyzed route to 3-alpha-difluoromethyl indoles. This method offers high yields and broad scope for pharmaceutical manufacturing.
Patent CN111978218A introduces a cost-effective florfenicol synthesis using sulfuryl fluoride, replacing hazardous Ishikawa reagents for safer, scalable veterinary API manufacturing.
Novel synthesis route for high-purity pharmaceutical intermediate offering safety and scale-up advantages for global supply chains and cost reduction.
Patent CN115894349A reveals a novel borylation-fluorination route for 2,3-difluoro-5-chloropyridine, offering high purity and cost reduction in agrochemical manufacturing.
Patent CN103420842B reveals a novel route for 2,3,4-trifluoronitrobenzene offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel halomethylation method for Sevoflurane using hexafluoroisopropanol. Reduces waste, improves yield, suitable for large-scale pharmaceutical manufacturing.
Patent CN117964497A reveals a scalable synthesis route for 3,3-difluoro cyclopentylamine hydrochloride, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel fluorination strategy enhances anti-tumor activity. Reliable supply chain for high-purity pharmaceutical intermediates with optimized synthesis routes.
Patent CN107382956A reveals high-yield synthesis for fluorine intermediates. Enables cost reduction in fine chemical manufacturing and reliable supply chain.
Patent CN102285919A reveals a gold-catalyzed route for 4-fluoro pyrazoles. Mild conditions, high yields, and broad substrate scope ensure cost-effective manufacturing for pharma intermediates.
Novel Selectfluor-mediated method avoids toxic acryloyl chloride. High yield, green process for reliable pharmaceutical intermediate supply.
Patent CN115583635A reveals a novel LiFSI synthesis route avoiding SO2 gas. Enhances supply chain reliability and purity for battery energy storage materials.
Patent CN116375611A details an efficient photocatalytic method for difluorination. Enhance metabolic stability in drug candidates with our scalable intermediates.
Patent CN108409648B details an energy-efficient synthesis of sorafenib intermediates with high purity, offering significant cost reduction in API manufacturing and scalable production capabilities.
Novel 2-fluoroadenine synthesis patent CN105130989A offers high yield and safety. Enables cost reduction in pharma manufacturing and reliable supply chain for antiviral drugs.
Patent CN113845436B reveals a metal-free photocatalytic method for defluorination, offering cost reduction and scalable synthesis for high-purity fluorinated intermediates.
Patent CN116283759B reveals high-yield quinoline synthesis. Enables cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Novel copper-catalyzed synthesis method offers high purity and cost efficiency. Ideal for pharmaceutical intermediates manufacturing with scalable supply chain solutions for global buyers.